Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMural Oncology plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$2.08 | -$1.89 | -$1.99 |
| Q2 2025 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q3 2025 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q1 2026 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q2 2026 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2026 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q1 2027 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q2 2027 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2027 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q4 2027 | 1 | -$0.74 | -$0.74 | -$0.74 |
Mural Oncology plc Earnings Date And Information
Mural Oncology plc last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.59 by $0.38. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mural Oncology plc has generated $-8 earnings per share over the last year ($-7.58 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. Mural Oncology plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 10th, 2026 based on prior year's report dates.
Mural Oncology plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$0.59 | -$0.21 | 0.38 | $0 | $0 |
| 08/04/2025 | Q2 2025 | -$1.13 | -$2.78 | -1.65 | $0 | $0 |
| 05/14/2025 | Q1 2025 | -$2.12 | -$1.93 | 0.19 | $0 | $0 |
| 03/11/2025 | Q4 2024 | -$1.98 | -$2.01 | -0.03 | $0 | $0 |
| 11/13/2024 | Q3 2024 | -$1.96 | -$1.87 | 0.09 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$1.90 | -$1.86 | 0.04 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$2.66 | -$1.84 | 0.82 | N/A | $0 |
| 03/26/2024 | Q4 2023 | N/A | -$3.57 | N/A | N/A | $0 |
| 12/14/2023 | Q3 2023 | N/A | -$3.07 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$3.13 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$2.78 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$3.52 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$3.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mural Oncology plc Earnings: FAQ's
Mural Oncology plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 10th, 2026 based offlast year's report dates.
In the previous quarter, Mural Oncology plc (:MURA) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.59 by $0.38.
The conference call for Mural Oncology plc's latest earnings report can be listened to online.
The conference call transcript for Mural Oncology plc's latest earnings report can be read online.
Mural Oncology plc (:MURA) has a recorded net income of $-128,514,000.Mural Oncology plc has generated $-7.58 earnings per share over the last four quarters.
Mural Oncology plc (:MURA) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is 0.02.